Researchers from Sanford Burnham Prebys have revealed a new function for a previously-known immune molecule, a discovery with implications for the treatment of autoimmune and gastrointestinal diseases.
San Diego group has provided more than $2 million to early-career scientists across the country conducting maverick research on Type 1 diabetes, including the lab run by developmental geneticist Duc Dong at Sanford Burnham Prebys.